The pharmaceutical landscape for blood sugar is changing, and GLP-1 patches represent a exciting breakthrough. Unlike subcutaneous injections, this approach offers a more convenient way to provide GLP-1 drugs. These devices gradually release the drug through the epidermis offering a consistent am